The Diabetes Control and Complications Trial (DCCT) which randomized people with T1D to receive intensive or standard insulin therapy; after 21 months 216 of 817 subjects had already experienced a severe hypoglycemic episode. This evidence concerns the gene INS and diabetes mellitus.